| Name | Steward Organization | Suggested Domain | Suggested Domain Description | Cde Group | Classification |
|---|---|---|---|---|---|
| Multum Phamacologic category #1 | MIDUS | Treatment |
Treatment for all conditions |
Studies in LINKAGE |
|
| # | Datatype | Datatype value list datatype |
|---|---|---|
|
|
Value List | Number |
| # | Permissible value | Value meaning name |
|---|---|---|
|
|
918 | ALPHA1 AGONIST |
|
|
919 | ALPHA 1 BLOCKER |
|
|
928 | ALPHA-/BETA- AGONIST |
|
|
930 | ALPHA2-ADRENERGIC AGONIST |
|
|
934 | AMEBICIDE |
|
|
938 | 5-AMINOSALICYLIC ACID DERIVATIVE |
|
|
947 | ANALGESIC, NONOPIOID |
|
|
953 | ANALGESIC, MISCELLANEOUS |
|
|
957 | ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR |
|
|
958 | ANGIOTENSIN II RECEPTOR BLOCKER |
|
|
961 | ANTACID |
|
|
971 | ANTIANGINAL AGENT |
|
|
976 | ANTIARRHYTHMIC AGENT, CLASS IB |
|
|
979 | ANTIARRHYTHMIC AGENT, CLASS III |
|
|
980 | ANTIARRHYTHMIC AGENT, CLASS IV |
|
|
983 | ANTIARRHYTHMIC AGENT, MISCELLANEOUS |
|
|
994 | ANTIBIOTIC, CEPHALOSPORIN (FIRST GENERATION) |
|
|
995 | ANTIBIOTIC, CEPHALOSPORIN (SECOND GENERATION) |
|
|
1002 | ANTIBIOTIC, MACROLIDE |
|
|
1004 | ANTIBIOTIC, OPHTHALMIC |
|
|
1009 | ANTIBIOTIC, QUINOLONE |
|
|
1011 | ANTIBIOTIC, SULFONAMIDE DERIVATIVE |
|
|
1017 | ANTIBIOTIC, MISCELLANEOUS |
|
|
1019 | ANTICHOLINERGIC AGENT |
|
|
1023 | ANTICOAGULANT, COUMARIN DERIVATIVE |
|
|
1032 | ANTICONVULSANT, MISCELLANEOUS |
|
|
1044 | ANTIDEPRESSANT, ALPHA-2 ANTAGONIST |
|
|
1050 | ANTIDEPRESSANT, SELECTIVE SEROTONIN REUPTAKE INHIBITOR |
|
|
1051 | ANTIDEPRESSANT, SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITOR |
|
|
1052 | ANTIDEPRESSANT, SEROTONIN REUPTAKE INHIBITOR/ANTAGONIST |
|
|
1054 | ANTIDEPRESSANT, TETRACYCLIC |
|
|
1057 | ANTIDEPRESSANT, TRICYCLIC (SECONDARY AMINE) |
|
|
1058 | ANTIDEPRESSANT, TRICYCLIC (TERTIARY AMINE) |
|
|
1062 | ANTIDIABETIC AGENT, ALPHA-GLUCOSIDASE INHIBITOR |
|
|
1063 | ANTIDIABETIC AGENT, BIGUANIDE |
|
|
1065 | ANTIDIABETIC AGENT, SULFONYLUREA |
|
|
1066 | ANTIDIABETIC AGENT, THIAZOLIDINEDIONE |
|
|
1069 | ANTIDIARRHEAL |
|
|
1074 | ANTIDOTE |
|
|
1124 | ANTIFIBRINOLYTIC AGENT |
|
|
1130 | ANTIFUNGAL AGENT, ORAL |
|
|
1134 | ANTIFUNGAL AGENT, TOPICAL |
|
|
1138 | ANTIGOUT AGENT |
|
|
1139 | ANTIHEMOPHILIC AGENT |
|
|
1156 | ANTIHYPERTENSIVE |
|
|
1165 | ANTI-INFLAMMATORY AGENT, OPHTHALMIC |
|
|
1170 | ANTILIPEMIC AGENT, FIBRIC ACID |
|
|
1171 | ANTILIPEMIC AGENT, HMG-COA REDUCTASE INHIBITOR |
|
|
1174 | ANTIMANIC AGENT |
|
|
1177 | ANTIMIGRAINE AGENT |
|
|
1195 | ANTINEOPLASTIC AGENT, AROMATASE INHIBITOR |
|
|
1219 | ANTI-PARKINSON'S AGENT, ANTICHOLINERGIC |
|
|
1225 | ANTIPLATELET AGENT |
|
|
1259 | ANTIRHEUMATIC, DISEASE MODIFYING |
|
|
1267 | ANTITUBERCULAR AGENT |
|
|
1277 | ANTIVIRAL AGENT |
|
|
1280 | ANTIVIRAL AGENT, ORAL |
|
|
1289 | BENZODIAZEPINE |
|
|
1291 | BETA-BLOCKER, BETA-1 SELECTIVE |
|
|
1293 | BETA-BLOCKER, NONSELECTIVE |
|
|
1294 | BETA-BLOCKER WITH ALPHA-BLOCKING ACTIVITY |
|
|
1299 | BETA2 AGONIST |
|
|
1305 | BISPHOSPHONATE DERIVATIVE |
|
|
1313 | CALCIUM CHANNEL BLOCKER |
|
|
1314 | CALCIUM SALT |
|
|
1318 | CARDIAC GLYCOSIDE |
|
|
1363 | CORTICOSTEROID, INHALANT (ORAL) |
|
|
1364 | CORTICOSTEROID, NASAL |
|
|
1365 | CORTICOSTEROID, OPHTHALMIC |
|
|
1366 | CORTICOSTEROID, OTIC |
|
|
1369 | CORTICOSTEROID, SYSTEMIC |
|
|
1370 | CORTICOSTEROID, TOPICAL |
|
|
1380 | DECONGESTANT |
|
|
1387 | DEPIGMENTING AGENT |
|
|
1390 | DIAGNOSTIC AGENT |
|
|
1428 | DIETARY SUPPLEMENT |
|
|
1435 | DIURETIC, LOOP |
|
|
1437 | DIURETIC, OSMOTIC |
|
|
1438 | DIURETIC, POTASSIUM SPARING |
|
|
1439 | DIURETIC, THIAZIDE |
|
|
1447 | ELECTROLYTE SUPPLEMENT, ORAL |
|
|
1448 | ELECTROLYTE SUPPLEMENT, PARENTERAL |
|
|
1449 | ENZYME |
|
|
1481 | GALLSTONE DISSOLUTION AGENT |
|
|
1488 | GASTROINTESTINAL AGENT, MISCELLANEOUS |
|
|
1504 | HEMOSTATIC AGENT |
|
|
1507 | HISTAMINE H2 ANTAGONIST |
|
|
1523 | HYPNOTIC, MISCELLANEOUS |
|
|
1528 | IMMUNOSUPPRESSANT AGENT |
|
|
1534 | IRON SALT |
|
|
1536 | KERATOLYTIC AGENT |
|
|
1539 | LAXATIVE, BULK-PRODUCING |
|
|
1545 | LAXATIVE, STIMULANT |
|
|
1551 | LEUKOTRIENE RECEPTOR ANTAGONIST |
|
|
1576 | MAGNESIUM SALT |
|
|
1596 | NEUROMUSCULAR BLOCKER AGENT, NONDEPOLARIZING |
|
|
1599 | NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) |
|
|
1600 | NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID), COX-2 SELECTIVE |
|
|
1602 | NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID), ORAL |
|
|
1603 | NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID), PARENTERAL |
|
|
1604 | NUTRITIONAL SUPPLEMENT |
|
|
1607 | OPHTHALMIC AGENT, ANTIGLAUCOMA |
|
|
1609 | OPHTHALMIC AGENT, MYDRIATIC |
|
|
1613 | OPHTHALMIC AGENT, VISCOELASTIC |
|
|
1629 | PHOSPHATE BINDER |
|
|
1646 | PROSTAGLANDIN |
|
|
1651 | PROTON PUMP INHIBITOR |
|
|
1665 | SALICYLATE |
|
|
1671 | SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM) |
|
|
1687 | SKIN AND MUCOUS MEMBRANE AGENT, MISCELLANEOUS |
|
|
1710 | THYROID PRODUCT |
|
|
1712 | TOPICAL SKIN PRODUCT |
|
|
1718 | TRACE ELEMENT |
|
|
1742 | VASODILATOR |
|
|
1750 | VITAMIN |
|
|
1753 | VITAMIN, FAT SOLUBLE |
|
|
1756 | VITAMIN, WATER SOLUBLE |
|
|
1757 | XANTHINE OXIDASE INHIBITOR |
|
|
1762 | SEROTONIN 5-HT1B, 1D RECEPTOR AGONIST |
|
|
1768 | HISTAMINE H1 ANTAGONIST |
|
|
1777 | UNDOCUMENTED CODE |
|
|
1779 | 5 ALPHA-REDUCTASE INHIBITOR |
|
|
1780 | SELECTIVE ALDOSTERONE BLOCKER |
|
|
1781 | ANTILIPEMIC AGENT, 2-AZETIDINONE |
|
|
1784 | PARATHYROID HORMONE ANALOG |
|
|
1814 | GONADOTROPIN RELEASING HORMONE AGONIST |
|
|
1820 | ANTIRHEUMATIC, MISCELLANEOUS |
|
|
1822 | ANTINEOPLASTIC AGENT, ANTIMETABOLITE (ANTIFOLATE) |
|
|
1823 | ANTIPROTOZOAL, NITROIMIDAZOLE |
|
|
1824 | SUBSTITUTED BENZIMIDAZOLE |
|
|
1825 | ANTISEPTIC, TOPICAL |
|
|
1827 | ANTIPSYCHOTIC AGENT, ATYPICAL |
|
|
1828 | ANTIPSYCHOTIC AGENT, TYPICAL |
|
|
1830 | AMINO ACID |
|
|
320122 | ANTISEPTIC, VAGINAL |
|
|
363221 | ANTIDIABETIC AGENT, MEGLITINIDE DERIVATIVE |
|
|
370141 | INSULIN, RAPID-ACTING |
|
|
580286 | ANTIDIABETIC AGENT, DIPEPTIDYL PEPTIDASE IV (DPP-IV) INHIBITOR |
|
|
923978 | ANTINEOPLASTIC AGENT, GONADOTROPIN-RELEASING HORMONE AGONIST |
|
|
1118479 | RESPIRATORY FLUOROQUINOLONE |
|
|
1160459 | BETA2-ADRENERGIC AGONIST, LONG-ACTING |
|
|
1163619 | NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID), TOPICAL |
|
|
1177583 | HISTAMINE H1 ANTAGONIST, SECOND GENERATION |
|
|
1177584 | HISTAMINE H1 ANTAGONIST, FIRST GENERATION |
|
|
1232826 | VITAMIN K ANTAGONIST |
|
|
1284841 | HISTONE DEACETYLASE INHIBITOR |
|
|
1711459 | LYSINE ANALOG |
|
|
1797079 | CALCIUM CHANNEL BLOCKER, NONDIHYDROPYRIDINE |
|
|
1797080 | CALCIUM CHANNEL BLOCKER, DIHYDROPYRIDINE |
|
|
1801719 | CALCINEURIN INHIBITOR |
|
|
1826674 | ANTIPLATELET AGENT, THIENOPYRIDINE |
|
|
2952225 | ALKYLAMINE DERIVATIVE |
|
|
2952299 | ETHANOLAMINE DERIVATIVE |
|
|
2952340 | PIPERAZINE DERIVATIVE |
|
|
2952559 | PIPERIDINE DERIVATIVE |
|
|
2965759 | FIBER SUPPLEMENT |
|
|
3819764 | BETA3 AGONIST |
|
|
3861322 | PHOSPHODIESTERASE ENZYME INHIBITOR, NONSELECTIVE |
|
|
3861323 | PHOSPHODIESTERASE-3 ENZYME INHIBITOR |
|
|
3974202 | ANTILIPEMIC AGENT, OMEGA-3 FATTY ACIDS |
|
|
3988862 | ANTICHOLINERGIC AGENT, LONG-ACTING |
|
|
9999999 | INAPP |
| # | Identifier | Origin | Version |
|---|---|---|---|
|
|
Survey of Midlife in Japan (MIDJA 2): Biomarker Project, 2013-2014 (ICPSR 36530)/#/0002_MIDJA_2_Stacked_Medications_Data_K2MPC1 | MIDUS-study_name+variable_name | ICPSR 36530 |